Approval of a coronavirus vaccine would be just the beginning — huge production challenges could cause long delays

Type: Print/ DigitalOutlet: HealthlineOutlet: The Conversation USTopic: Epidemic/Pandemic Preparedness and Response

Aug 24

Written By Alexis Dibbs

Vaccine Needs 80 Percent Efficiency With 75 Percent Uptake to Stop Pandemic in U.S.

Here’s What We Know About the Demographic Makeup of the COVID-19 Vaccine TrialsShare on Pinterest